Gregory Susan J, Lacza Charlemagne T, Detz Alissa A, Xu Shuyun, Petrillo Laura A, Kaiser Ursula B
Brigham and Women's Hospital and Harvard Medical School, Division of Endocrinology, Diabetes and Hypertension, 221 Longwood Avenue, Boston, Massachusetts 02115, USA.
Mol Endocrinol. 2005 Jan;19(1):237-54. doi: 10.1210/me.2003-0473. Epub 2004 Sep 16.
Both activin and GnRH can independently stimulate expression of the FSHbeta subunit gene. In this study, we used the gonadotrope-derived LbetaT2 cell line to investigate the potential interaction between activin and GnRH in regulating the transcriptional activity of the rat FSHbeta gene promoter. Activin A and GnRH synergistically enhanced rat FSHbeta transcriptional activity. Overexpression of SMAD3 (mediator of decapentaplegic-related protein 3), but not of SMAD2, increased transcriptional activation of the rat (r) FSHbeta gene promoter, which was further enhanced by the combined overexpression of SMAD3 and 4 (3+4). The stimulatory effects of SMAD3 overexpression were localized to -472/-256 of the rFSHbeta gene promoter, and activin- and GnRH-responsive proteins were shown to bind to region -284/-252. Sequence analysis identified a consensus palindromic SMAD-binding site at -266/-259 of the rFSHbeta gene promoter. Mutation of two bases located in the center of this palindrome effectively abrogated SMAD4 binding, markedly reduced SMAD3 and 3+4 stimulation of the rFSHbeta gene promoter, and significantly decreased the synergistic enhancement of promoter activity by both activin A and GnRH, and SMAD3 and GnRH. Blockade of the MAPK-signaling pathway did not significantly affect the response to combined stimulation with activin and GnRH. In contrast, interference with SMAD3 signaling caused a significant reduction in activin and GnRH synergy. The results indicate that SMAD3 plays an important role in the synergistic effects of activin and GnRH and demonstrate that this synergy is mediated by a palindromic cis-element located at -266/-259 of the rFSHbeta gene promoter.
激活素和促性腺激素释放激素(GnRH)均可独立刺激促卵泡激素β亚基基因的表达。在本研究中,我们使用源自促性腺细胞的LβT2细胞系,来研究激活素与GnRH在调节大鼠促卵泡激素β基因启动子转录活性方面的潜在相互作用。激活素A与GnRH协同增强大鼠促卵泡激素β的转录活性。过表达SMAD3(果蝇同源基因相关蛋白3的介质)而非SMAD2,可增加大鼠(r)促卵泡激素β基因启动子的转录激活,而SMAD3和4(3 + 4)的联合过表达可进一步增强这种激活。SMAD3过表达的刺激作用定位于r促卵泡激素β基因启动子的-472 / -256区域,且激活素和GnRH反应蛋白可与-284 / -252区域结合。序列分析在r促卵泡激素β基因启动子的-266 / -259处鉴定出一个共有回文SMAD结合位点。该回文中心的两个碱基发生突变可有效消除SMAD4结合,显著降低SMAD3和3 + 4对r促卵泡激素β基因启动子的刺激,并显著降低激活素A与GnRH以及SMAD3与GnRH对启动子活性的协同增强作用。阻断丝裂原活化蛋白激酶(MAPK)信号通路对激活素与GnRH联合刺激的反应无显著影响。相反,干扰SMAD3信号传导会导致激活素与GnRH协同作用显著降低。结果表明,SMAD3在激活素与GnRH的协同作用中起重要作用,并证明这种协同作用由位于r促卵泡激素β基因启动子-266 / -259处的回文顺式元件介导。